Introduction {#sec1-1}
============

Heart failure (HF) is a leading cause of cardiovascular mortality and morbidity, and it is associated with high costs that are burdening health care systems ([@ref1]). Approximately 6.5 million adults suffer from HF in the United States ([@ref2]). According to data from the Heart Failure Prevalence and Predictors in Turkey (HAPPY) study, the estimated prevalence of HF is 2.9% in Turkey, which means that 2.000.424 Turkish adults have HF ([@ref3]). This huge population needs age-specific prudent care to decrease the burden of the disease in Turkey.

The incidence and prevalence of HF gradually increase with advanced age. The number of elderly patients is also increasing in our population. Nearly 8.6% of total population is aged ≥85 years in Turkey ([@ref4]). Furthermore, as the population gets older, the prevalence of HF continues to increase ([@ref5]). This is due to progressive aging of the population, as well as the improvements in the HF survival over the years. In addition to its high prevalence, the disease also has a poor prognosis and high mortality rate in elderly patients. The 5-year mortality rate for 80-year-olds with HF is as high as 54.4% ([@ref2]). Although HF has a markedly high mortality rate and prevalence in the elderly, few studies have focused on patients with HF who are older than 80 years. In large clinical trials, this growing population is underrepresented or excluded. However, patients aged ≥80 years show a different clinical profile when compared with younger patients. Patients aged ≥80 years with HF have a complex comorbidity and a high number of cardiovascular risk factors, which have a significant impact on the prognosis of the disease ([@ref6]). Moreover, the effective treatment of chronic cardiovascular disorders, such as coronary artery disease (CAD), hypertension (HT), and diabetes mellitus (DM), may prevent the progression of HF.

Traditionally, HF has been defined as failure of the contractile function of the left ventricle. However, it is recognized that the HF symptoms can occur in the presence of normal or near-normal EF, which is defined as HF with preserved ejection fraction (HFpEF). HFpEF and HFrEF have different clinical characteristics and prognostic factors. Patients with HFpEF are more often female and are more likely to have HT but less likely to have CAD. A recent meta-analysis suggests that patients with HFpEF may have a lower mortality rate than those with HFrEF ([@ref7]). Altough all these differences are well known to affect the prognosis and the clinical outcome of elderly patients with HF, there is not much evidence, especially considering those issues related to specific characteristics of the elderly with HFrEF and HFpEF. Further studies are required to determine specific clinical characteristics of patients aged ≥80 years with HFrEF and HFpEF to produce a contemporary management strategy. The objective of this study is to determine clinical characteristics and major comorbidities of Turkish patients aged ≥80 years with HFrEF and HFpEF, and to compare them with patients aged 65-79 years.

Methods {#sec1-2}
=======

Study design {#sec2-1}
------------

In this study, we used data of 5694 patients aged ≥65 years who were recruited from the ELDER--TURK study, which was conducted in 73 volunteering hospital cardiology clinics participating in 12 EUROSTAT NUTS1 regions of Turkey ([Fig. 1](#F1){ref-type="fig"}, [Table 1](#T1){ref-type="table"}). The design and details of this study have been reported before ([@ref8]-[@ref10]).

![Twelve NUTS regions of Turkey](AJC-21-196-g001){#F1}

###### 

List of participating centers and NUTS1 regions

                                                                                                    Percentage (%) of total patient population   Percentage (%) of total Turkish population
  --------------------------- -------------------------------------------------------------- ------ -------------------------------------------- --------------------------------------------
  1\) İstanbul                Pendik State Hospital                                          398                                                 
                              Şişli Etfal Training and Research Hospital                     231                                                 
                              Kartal KoşuyoluYüksek İhtisas Training and Research Hospital   208                                                 
                              Okmeydanı Training and Research Hospital                       94                                                  
                              İstanbul University, Cardiology Institute                      83                                                  
                              GATA Haydarpaşa                                                77                                                  
                              İstinye State Hospital                                         75                                                  
                              Türkiye Hospital/Memorial Hospital                             43                                                  
                              Surp Pirgiç Ermeni Training and Research Hospital              17                                                  
                              Medipol University Faculty of Medicine                         5                                                   
                              Mehmet Akif Ersoy Training and Research Hospital               40                                                  
  Total                                                                                      1271   22.32                                        16.5
  2\) West Anatolia           Mevlana University Faculty of Medicine                         104                                                 
                              Selçuk University Faculty of Medicine                          31                                                  
                              Başkent University Faculty of Medicine                         41                                                  
                              Gazi University Faculty of Medicine                            15                                                  
                              GATA Ankara                                                    41                                                  
                              TürkiyeYüksek İhtisas Training and Research Hospital           428                                                 
                              Hacettepe University Faculty of Medicine                       87                                                  
                              Ankara University Faculty of Medicine                          40                                                  
                              Keçiören Training and Research Hospital                        43                                                  
                              Yenimahalle Training and Research Hospital                     234                                                 
                              Ereğli State Hospital                                          1                                                   
                              Turgut Özal University Faculty of Medicine                     4                                                   
  Total                                                                                      1069   18.77                                        13.88
  3\) East Marmara            Sakarya Training and Research Hospital                         9                                                   
  Total                                                                                      9      0.15                                         0.11
  4\) Eagean Region           Ege University Faculty of Medicine                             366                                                 
                              Muğla Sıtkı Koçman University Faculty of Medicine              142                                                 
                              Muğla Yücelen Private Hospital                                 127                                                 
                              Menemen State Hospital                                         74                                                  
                              Manisa State Hospital                                          61                                                  
                              Gazi Emir State Hospital                                       44                                                  
                              Aksaz Military Hospital                                        40                                                  
                              Denizli State Hospital                                         40                                                  
                              Denizli Server Gazi State Hospital                             40                                                  
                              Kemalpaşa State Hospital                                       40                                                  
                              Kent Hospital                                                  40                                                  
                              İzmir Tepecik Training and Research Hospital                   38                                                  
                              Manisa Demirci State Hospital                                  24                                                  
                              İzmir Military Hospital                                        120                                                 
                              Afyon State Hospital                                           114                                                 
                              Bolvadin State Hospital                                        40                                                  
                              Afyon Kocatepe University Faculty of Medicine                  8                                                   
  Total                                                                                      1358   23.84                                        17.63
  5\) West Marmara            Edirne State Hospital                                          7                                                   
                              Tekirdağ State Hospital                                        60                                                  
                              Namık Kemal University Faculty of Medicine                     46                                                  
  Total                                                                                      113    1.98                                         1.46
  6\) Mediterranean           Antalya Atatürk State Hospital                                 137                                                 
                              Tarsus State Hospital                                          126                                                 
                              Akdeniz University Faculty of Medicine                         120                                                 
                              Mustafa Kemal Univercity Training and Research Hospital        65                                                  
                              Necip Fazıl State Hospital                                     57                                                  
                              Antalya Training and Research Hospital                         55                                                  
                              Antakya Defne Private Hospital                                 40                                                  
                              Isparta State Hospital                                         19                                                  
                              Süleyman Demirel University Faculty of Medicine                1                                                   
                              Antalya OFM Private Hospital                                   2                                                   
                              Mersin University Faculty of Medicine                          8                                                   
                              Osmaniye State Hospital                                        8                                                   
  Total                                                                                      638    11.2                                         8.28
  7\) West Black Sea          Samsun Training and Research Hospital                          15                                                  
                              Hitit University Faculty of Medicine                           153                                                 
                              Sinop State Hospital                                           3                                                   
                              Osmangazi University Faculty of Medicine                       10                                                  
  Total                                                                                      181    3.17                                         2.35
  8\) Middle Anatolia         Ahi Evren Thorasic and Cardiovascular                          12                                                  
                              Training and Research Hospital                                                                                     
                              Ahi Evran University Training and Research Hospital            219                                                 
                              Aksaray State Hospital                                         62                                                  
  Total                                                                                      293    5.14                                         3.8
  9\) East Black Sea          Rize Kaçkar State Hospital                                     340                                                 
  Total                                                                                      340    5.97                                         4.41
  10\) Southeast Anatolia     Mardin State Hospital                                          91                                                  
                              Siirt State Hospital                                           43                                                  
                              Gaziantep University Faculty of Medicine                       11                                                  
                              Gaziantep 25 Aralık State Hospital                             7                                                   
  Total                                                                                      152    2.66                                         1.97
  11\) Middle East Anatolia   Bingöl State Hospital                                          88                                                  
  Total                                                                                      88     1.54                                         1.14
  12\) Northeast Anatolia     Kars State Hospital                                            2                                                   
                              Bayburt State Hospital                                         53                                                  
                              Erzurum Training and Research Hospital                         64                                                  
                              Kafkas University Faculty of Medicine                          63                                                  
  Total                                                                                      182    3.19                                         2.36

In this population-based study, patients aged ≥65 years who were admitted to outpatient cardiology clinics and inpatient wards of state, university, private, and training and research hospitals between March 2015 and December 2015 were included after signing the informed consent for data sharing. In this study, elderly patients from the ELDER--TURK population with known HF (n=1681, 29.5%) were evaluated. As there is no specific classification cutoffs for elderly patients, in this study, participants aged ≥80 years were defined as being of an advanced age. The participants with HF were divided into two groups patients aged 65-79 years (n=1248) and patients aged ≥80 years (n=433). Cardiovascular diseases, risk factors, comorbidities, demographic characteristics, and the laboratory findings were analyzed and compared.

The study was approved by the Local Ethics Committee and was conducted according to the principles of the Declaration of Helsinki (as revised in Brasil, 2013).

The diagnosis of HF was established if the following HF symptoms were found: dyspnea, paroxysmal nocturnal dyspnea, and signs of pulmonary and/or peripheral congestion ([@ref11]). Left ventricular (LV) function was determined by two-dimensional transthorasic echocardiography, which was performed by a physician in all subjects participating in the study. Patients with HF signs and symptoms and a normal or mildly reduced LV systolic function (LVEF \>50%) with relevant structural heart disease (left atrial enlargement, LV hypertrophy) and/or diastolic dysfunction were classified as having HFpEF. Patients with HF symptoms and a reduced LV systolic function (LVEF ≤50%) were classified as having HFrEF ([@ref12]).

Cardiovascular diseases, risk factors, and comorbidities were recorded according to the self-reported history or hospital medical records.

The diagnosis of HF was established by the local investigators by combining information about history, clinical data, medications, and echocardiography. To be eligible for inclusion in the studies, patients were required to have a history of shortness of breath on minimal exertion or at rest \[New York Heart Association (NYHA) Class III or IV\], within the last month and had to be in NYHA Class II--IV at the time of randomization. Patients were also required to have been treated with a diuretic. The diagnosis of HF was established by the local investigators by combining information about history, clinical data, medications, and echocardiography. To be eligible for inclusion in the studies, patients were required to have a history of shortness of breath on minimal exertion or at rest (NYHA Class III or IV), within the last month and had to be in NYHA Class II--IV at the time of randomization. Patients were also required to have been treated with a diuretic.

The diagnosis of HF was established by the local investigators by combining information about history, clinical data, medications, and echocardiography. To be eligible for inclusion in the studies, patients were required to have a history of shortness of breath on minimal exertion or at rest (NYHA Class III or IV), within the last month and had to be in NYHA Class II--IV at the time of randomization. Patients were also required to have been treated with a diuretic.

The diagnosis of HF was established by the local investigators by combining information about history, clinical data, medications, and echocardiography. To be eligible for inclusion in the studies, patients were required to have a history of shortness of breath on minimal exertion or at rest (NYHA Class III or IV), within the last month and had to be in NYHA Class II--IV at the time of randomization. Patients were also required to have been treated with a diuretic.

Patients were defined as hypertensive if they were using antihypertensive medications or if they had high blood pressure on examination (systolic \>140 mm Hg or diastolic \>90 mm Hg) ([@ref13]). Patients who were newly diagnosed as diabetic or who were already using an oral hypoglycemic agent or insulin were reported as diabetic. The glomerular filtration rate (GFR) was calculated using the Modification of Diet in Renal Disease formula. Chronic renal failure (CRF) was defined as an estimated GFR \<60 mL/min for at least 3 months ([@ref14]). Smoking status was recorded as positive if the patients were an active smoker. Patients were considered as having CAD in the presence of previous myocardial infarction, stable or unstable CAD, a history of myocardial revascularization, and coronary artery by-pass graft operation ([@ref15]).

Statistical analysis {#sec2-2}
--------------------

All statistical analyses were performed using the SPSS program, version 21 (Chicago, IL, USA) for Windows XP. Data summary was planned to be shared by tables. Continuous variables were expressed as the mean±standard deviation. The chi-square test was used for categorical variables and was expressed as the number of cases and percentages (%). Mean differences between groups were compared by Student's t-test, whereas the Mann--Whitney U test was applied for comparisons of the not normally distributed data. Values for p\<0.05 were considered to indicate statistical significance.

Results {#sec1-3}
=======

Among 1089 patients aged ≥80 years (male, 47.5%; mean age, 83.5±3.1 years), 39.8% (433) had HF. The prevalence of CAD and peripheral artery disease (PAD), DM, and atrial fibrilation (AF) were higher in patients aged ≥80 years with HF when compared to those without HF (54.3% vs. 32.3%, 45.5% vs. 14.3%, 25.6% vs. 23%, 42.3% vs. 31.7%, respectively, all p\<0.01) whereas the prevalence of HT was higher in patients aged ≥80 years without HF (74.2% vs. 67%, p\<0.01). Approximately 9.9% of those patients with HF were smoking ([Table 2](#T2){ref-type="table"}). The prevalence of comorbidities in very elderly with HF were 25.4% for chronic obstructive pulmonary disease (COPD), 26.8% for anemia, and 19.9% for CRF. There was no age or gender difference between those with HF and without HF. The mean heart rate was significantly higher in patients with HF (76.4±14.3 vs. 80.5±18.5 p\<0.01). Laboratory values and demographic characteristics are given in [Table 2](#T2){ref-type="table"}. Nearly half of those patients with HF had HFrEF (50.1%, 217), and 49.9% (216) had HFpEF. The proportion of females was significantly higher in those with HFpEF (55.1%, 119) (p=0.019). The mean age was similar between the groups (83.8±3.2 vs. 83.7±3.3, p=0.457). When compared with patients aged ≥80 years with HFrEF, the prevalence of HT and DM were higher in those with HFpEF (75.9% vs. 58.1%, 29.2% vs. 22.1%, respectively, all p\<0.01). Whereas, the prevalence of CAD was significantly higher in patients aged ≥80 years with HFrEF (62.7% vs. 45.8%, p=0.02) ([Table 3](#T3){ref-type="table"}).

###### 

Comparison of demographics and prevalence of comorbid conditions and cardiovascular risk factors between the patients aged ≥80 years, with and without HF

  Parameter                HF (−) (n=656)   HF (+) (n=433)     *P* value
  ------------------------ ---------------- ------------------ -----------
  Female                   357 (54.4%)      214 (49.4%)        0.106
  Male                     299 (45.6%)      219(50.6%)         0.120
  Smoking                  49 (13.4%)       43 (9.9%)          0.149
  HT                       487 (74.2%)      290 (67%)          0.009
  DM                       157 (23%)        111 (25.6%)        \<0.001
  CAD                      212 (32.3%)      235 (54.3%)        \<0.001
  PAD                      94 (14.3%)       197 (45.5%)        \<0.001
  COPD                     116 (17.7%)      110 (25.4%)        0.581
  AF                       208 (31.7%)      183 (42.3%)        0.003
  Pacemaker                21 (3.2%)        30 (6.9%)          0.005
  CRF                      83 (12.6%)       86 (19.7%)         0.457
  Anemia                   123 (18.7%)      116 (26.8%)        0.001
  Age                      83.4±3.0         83.7±3.3           0.111
  Heart rate (betas/min)   76.4±14.3        80.5±18.5          \<0.001
  SBP (mm Hg)              131.1±17.0       127.4±18.5         0.043
  DBP (mm Hg)              76.7±10.8        75.5±12.1          0.097
  Hb (g/dL)                12.4±1.7         12.0±1.8           0.340
  TC (mg/dL)               193 (164-220)    180 (148-207)      0.174
  LDL (mg/dL)              118 (93-142)     106 (84-135)       0.245
  Kreatinin (mg/dL)        0.9 (0.8-1.1)    1 (0.8-1.3)        0.001
  eGFR (mL/min)            70 (55.4-83.4)   63.6 (48.7-79.5)   0.245

AF - atrial fibrilation; CAD - coronary artery disease; COPD - chronic obstructive pulmonary disease; CRF - chronic renal failure; DBP - diastolic blood pressure; DM - diabetes mellitus; eGFR - estimated glomerular filtration rate; Hb - hemoglobin; HF - heart failure; HT - hypertension; LDL - low-density lipoprotein; PAD - peripheral artery disease; SBP - systolic blood pressure; TC - total cholesterol

###### 

Demographics of patients aged ≥80 years, with HFrEF and HFpEF

  Parameter   HFrEF (n=217)   HFpEF (n=216)   *P* value
  ----------- --------------- --------------- -----------
  Female      95 (43.8%)      119 (55.1%)     0.019
  Male        122 (56.2%)     97 (44.9%)      0.024
  Smoking     27 (12.4%)      16 (7.4%)       0.078
  HT          126 (58.1%)     164 (75.9%)     \<0.001
  DM          48 (22.1%)      63 (29.2%)      0.003
  CAD         136 (62.7%)     99 (45.8%)      0.002
  PAD         96 (44.2%)      101 (46.8%)     0.350
  COPD        52 (24%)        58 (26.8%)      0.247
  AF          88 (40.5%)      95 (44%)        0.356
  Pacemaker   21 (9.7%)       9 (4.2%)        0.025
  CRF         48 (22.1%)      38 (17.6%)      0.350
  Anemia      57 (26.3%)      59 (27.3%)      0.254
  Age         83.8±3.2        83.7±3.3        0.457

AF - atrial fibrilation; CAD - coronary artery disease; COPD - chronic obstructive pulmonary disease; CRF - chronic renal failure; DM - diabtes mellitus; HFrEF - HF with reduced ejection fraction; HFpEF - HF with preserved ejection fraction;

HT - hypertension; LDL - low-density lipoprotein; PAD - peripheral artery disease

Among 4596 of patients aged 65-79 years (male, 50.2%; mean age, 71.1±4.31 years), 27.1% (1248) had HF. In those patients, the prevalence of HFrEF and HFpEF were 56.1% (700) and 43.9% (548), respectively. In the HFrEF group, DM had a higher frequency in patients aged 65--79 years when compared with patients aged ≥80 years (5.3% vs. 24.1%, p\<0.01). [Tables 3](#T3){ref-type="table"} and [4](#T4){ref-type="table"} represent comparison based on EF-related classification between patients with HF aged ≥80 years and patients with HF aged 65--79 years.

###### 

Comparison of clinical characteristics of very elderly and the youngers with HFpEF and HFrEF

  Parameter   Group I: 65-79 years with HFpEF 548 (43.9%)   Group II: ≥80 years with HFpEF 216 (49.9%)   *P* value   Group I: 65-79 years with HFrEF 700 (56.1%)   Group II: ≥80 years with HFrEF 217 (50.1%)   *P* value
  ----------- --------------------------------------------- -------------------------------------------- ----------- --------------------------------------------- -------------------------------------------- -----------
  HT (%)      426 (77.7%)                                   164 (75.9%)                                  0.591       455 (65%)                                     126 (58.1%)                                  0.064
  DM (%)      180 (32.8%)                                   63 (29.2%)                                   0.321       220 (31.4%)                                   48 (22.1%)                                   0.009
  CAD (%)     296 (54%)                                     99 (45.8%)                                   0.731       493 (70.4%)                                   136 (62.7%)                                  0.088
  CRF (%)     75 (13.7%)                                    38 (17.6%)                                   0.156       155 (22.1%)                                   48 (22.1%)                                   0.979
  COPD (%)    89 (16.2%)                                    35 (16.2%)                                   0.260       117 (16.7%)                                   36 (16.6%)                                   0.653
  AF (%)      204 (37.2%)                                   95 (44%)                                     0.469       282 (40.3%)                                   88 (40.5%)                                   0.607

AF - atrial fibrilation; CAD - coronary artery disease; COPD - chronic obstructive pulmonary disease; CRF - chronic renal failure; DM - diabtes mellitus; HFrEF - HF with reduced ejection fraction; HFpEF - HF with preserved ejection fraction; HT - hypertension

Discussion {#sec1-4}
==========

In this multi-centered, epidemiologic study, a large number of elderly patients with HF who were admitted to cardiology clinics were recruited. Significant epidemiologic data on cardiovascular disease and risk factors among Turkish elderly patients with HF were obtained. We observed significant differences between patients with HF aged 65--79 years and ≥80 years.

The age-specific prevalence of HF among patients aged 75--84 years was 22% in the CARLA study (German), 13% in the ROTTERDAM study (The Netherlands), and 8.4% in the Olmsted county study (USA) ([@ref5], [@ref16], [@ref17]). In patients aged ≥80 years, the prevalence of HF is 14.1% for males and 13.4% for females in the United States ([@ref2]). In southwestern Europe, the prevalence of HF for patients aged ≥80 years is 16.14% ([@ref18]). In those community-based epidemiological surveys, the prevalence of HF for the elderly population was lower than our finding in cardiology clinics in Turkey.

The prevalence of HFrEF progressively increases with advanced age and grows by 12%--14% in the population aged ≥80 years ([@ref19]). We observed that nearly half of the very elderly patients with HF had HFrEF in cardiology clinics, which was similar to the other large studies, such as the Framingham and Olmsted county study. In accordance with those large studies, among very elderly patients with HF, CAD was the most contributing factor to HF and was followed by HT ([@ref5], [@ref20], [@ref21]). CAD is also a strong predictor of all-cause mortality in the elderly ([@ref20], [@ref21]). In our study, CAD had a higher prevalence in patients aged ≥80 years with HF compared to those without HF.

In the TAKTIK study, the prevalence of CAD for patients hospitalized for acute HF in Turkey was 61% ([@ref22]). However, our finding was close to results of the EFHS II study ([@ref23]). In the EFHS II study, the prevalence of CAD in patients aged ≥80 years with HF was 51%, which is similar to our result. This observed difference between the studies might be due to the age distribution of study populations. The prevalence of cardiovascular comorbidities depends on age, but the relationship is not linear. All cardiovascular comorbidities gradually increase until the age of 80 years and then decrease ([@ref24], [@ref25]). In the EHFS II study, the mean age was similar to the one in our study; however, the mean age was lower in the TAKTIK study (62±13). As a consequence, the prevalence of CAD seems to be higher in the TAKTIK study. Nevertheless, the ELDER--TURK study includes both outpatient cardiology clinics and inpatient wards, which might have an impact on these reported different results.

As CAD is a predominantly caused by HF and has a higher prevalence in very elderly with HF, prevention of the onset of CAD is the key to reducing the burden of HF in cardiology clinics in Turkey. In our study, most of cardiovascular disease risk factors and comorbidities such as CAD, DM, PAD, AF, and anemia were higher in very elderly patients with HF, as shown in [Table 3](#T3){ref-type="table"}.

In contrast to EHFS II, the prevalence of HT in patients aged ≥80 years with HF was not statistically different than the patients aged 65--79 years with HF. In our study, the mean systolic blood pressure (SBP) was lower in very elderly patients with HF compared to those without HF, which means very elderly patients with HF were more hypotensive. This means those patients should be monitored more closely in cardiology clinics, and aggressive antihypersensive treatment should be avoided in those patients.

In very elderly with HFpEF, the proportion of females was higher, which was similar to large studies such as MAGGIC, HAPPY, PREFER, and CHARM ([@ref3], [@ref7], [@ref26], [@ref27]). In the CARLA study, single strongest determinant for HFpEF was HT, and this result was similar to our study; HT had a higher prevalence in very elderly patients with HFpEF compared to those with HFrEF. On the other hand, in accordance with the OPTIMIZE-HF, registry the frequency of DM was higher in patients with HFpEF compared to those with HFrEF ([@ref26]). Very elder patients with HFpEF were found to be older than patients with HFrEF in some studies that do not consider patients aged ≥80 years. However, in our study, there was no age difference between very elderly patients with HFrEF and HFpEF ([@ref28], [@ref29]). The prevalence of DM in patients aged ≥80 years with HFrEF was lower than in patients aged 65--79 years with HFrEF. This result was consistent with the EHFS I and II studies. This may be related to reduced likelihood of surviving in older patients with DM compared to those without DM.

One of the predictors of all-cause mortality in patients aged ≥70 years with HF is PAD ([@ref21]). In this study, PAD was significantly higher in very elderly with HF compared to those without HF.

AF has a great prognostic importance with regard to long-term mortality in very elderly with HF ([@ref30]). In our study, the prevalence of AF was lower in very elderly with HF compared to those without HF. This may be a satisfactory result for a better long-term survival in very elderly with HF in Turkey. In the EFHS II study, the prevalence of AF was 48% in patients aged ≥80 years with HF, and this was also close to our result ([@ref23]).

Smoking status should also be questioned and identified in cardiology clinics. The prevalence of smoking for very elderly with HF was as high as for those without HF in our study. The cardiologist should be focused more on smoking-cessation efforts for primary care in those patients. Smokers need to be identified and offered pharmacological or behavioral smoking-cessation support. Moreover, guidelines should focus on smoking cessation for very elderly with HF.

In our study, the prevalence of COPD in very elderly with HF was higher than in the EHFS II study ([@ref23]), whereas the prevalence of renal failure was similar with the HAPPY cohort ([@ref25]). Renal failure is a strong predictor of both in-hospital mortality and follow-up mortality ([@ref31]). In our study, the mean creatinine value was significantly higher in very elderly with HF, which may be associated with poor outcome.

Study limitations {#sec2-3}
-----------------

This study included only patients who were admitted to outpatient cardiology clinics and inpatient wards. Hence, the prevalence of HF is higher than in the population-based studies. This is thought to be the cause of selection bias and is one of the study limitations.

Very elderly who were followed up at outpatient wards were less frail and were functioning better, and we believe that this led to underestimated prevalence of cardiovascular disease and risk factors. In addition, some comorbidities lead to a reduced survival rate. This could also have caused underestimated prevalence of CAD and risk factors, such as DM.

Conclusion {#sec1-5}
==========

In this study, we provide a national database about the prevalence of cardiovascular diseases, risk factors, and comorbidities of a large population of Turkish elderly patients with HF and compare it with other large studies. Despite the high prevalence of comorbidities and risk factors, there is no evidence-based therapy for the treatment of very elderly with HF. Consequently, there is a need to develop more effective and targeted management strategies for this population.
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